Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Abbott’s New Use for Top Drug Humira Delayed by U.S.
May 24, 2012
Abbott’s bid to expand use of its best-selling arthritis treatment Humira to ulcerative colitis patients is being delayed by U.S. regulators.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing